bromocriptine has been researched along with flavoxate in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Milroy, E | 1 |
| Peters, FD; Schumacher, T | 1 |
1 review(s) available for bromocriptine and flavoxate
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for bromocriptine and flavoxate
| Article | Year |
|---|---|
Pharmacological management of common urodynamic problems.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Antidepressive Agents, Tricyclic; Bromocriptine; Diazepam; Enuresis; Female; Flavoxate; Humans; Male; Muscle, Smooth; Parasympatholytics; Urethra; Urinary Bladder; Urinary Bladder, Neurogenic; Urinary Incontinence; Urination Disorders | 1979 |
[Possibilities of the drug modification of the urethra and urinary bladder].
Topics: Baclofen; Bromocriptine; Dantrolene; Flavoxate; Humans; Imipramine; Male; Parasympatholytics; Parasympathomimetics; Prostaglandins; Sympatholytics; Sympathomimetics; Urethra; Urinary Bladder | 1983 |